Ligand Pharmaceuticals
LGND
LGND
259 hedge funds and large institutions have $2.5B invested in Ligand Pharmaceuticals in 2016 Q3 according to their latest regulatory filings, with 27 funds opening new positions, 109 increasing their positions, 91 reducing their positions, and 32 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less call options, than puts
Call options by funds: $ | Put options by funds: $
less first-time investments, than exits
New positions opened: | Existing positions closed:
16% less capital invested
Capital invested by funds: $2.97B → $2.5B (-$475M)
50% less funds holding in top 10
Funds holding in top 10: 14 → 7 (-7)
Holders
259
Holding in Top 10
7
Calls
$12.4M
Puts
$14M
Top Buyers
| 1 | +$95.9M | |
| 2 | +$22.5M | |
| 3 | +$19.3M | |
| 4 |
O
OppenheimerFunds
New York
|
+$18.7M |
| 5 |
State of New Jersey Common Pension Fund D
Trenton,
New Jersey
|
+$15.3M |
Top Sellers
| 1 | -$55.2M | |
| 2 | -$30M | |
| 3 | -$29.6M | |
| 4 |
William Blair Investment Management
Chicago,
Illinois
|
-$27.8M |
| 5 |
DMK
David M. Knott
|
-$20.6M |